Understanding sound perception in infants with Fragile X Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how infants and toddlers with Fragile X Syndrome (FXS) perceive sound and language compared to typically developing children. Using a combination of behavioral assessments, neuroimaging techniques like EEG and fNIRS, and hearing tests, the research aims to identify early markers of speech and language impairments in this population. The study will track 30 infants over time, assessing their responses to various auditory stimuli at different developmental stages. By focusing on the neural mechanisms underlying sound perception, the study seeks to enhance understanding of language delays associated with FXS.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnoses of Fragile X Syndrome, Typical Development, or History of Premature Birth
* able to sit independently
* English is spoken at home

Exclusion Criteria:

* For all participants: no seizures in the past 6 months
* For typical development group and Fragile X group: not born prior to 32 weeks gestation

Where it's running

• Cincinnati Children's Hospital
  Cincinnati, Ohio, United States Recruiting

Study contacts

• Study coordinator: Elizabeth Smith, PhD
• Email: elizabeth.smith3@cchmc.org
• Phone: 5135171383

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CTH120 in Fragile X syndrome: safety and early effectiveness in adult males

  This study tests CTH120 versus placebo to see if it is safe and helps adults with Fragile X syndrome.

  Recruiting at 2 sites Phase 2 Connecta Therapeutics, S.L. · Barcelona, Barcelona and 1 other locations · NCT07654114

• MRM-3379 for males with Fragile X Syndrome (BLOOM)

  This trial will test three doses of the oral drug MRM-3379 in males with Fragile X Syndrome aged 16–45 (placebo-controlled), with a parallel open-label group for ages 13–15.

  Recruiting at 17 sites Phase 2 Mirum Pharmaceuticals, Inc. · Phoenix, Arizona and 17 other locations · NCT07209462

• Inclusive physical activity program for adults with intellectual disabilities

  This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.

  Recruiting University of North Carolina, Chapel Hill · Fayetteville, Arkansas and 1 other locations · NCT06740162

• Cannabidiol for Anxiety and GABA Function in Fragile X Syndrome

  This study tests a cannabidiol oral solution to see if it helps anxiety and brain signaling in people with Fragile X syndrome.

  Recruiting Phase 2 Université de Sherbrooke · Sherbrooke, Quebec · NCT06261502

• Using sound to improve cognitive function and sensory sensitivity in youth with developmental disorders

  This study is testing if listening to special sounds can help improve thinking skills and reduce sensitivity to noise in children with Fragile X Syndrome and Autism Spectrum Disorder.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT06227780

• Non-invasive prenatal diagnosis for single gene disorders

  This study is testing a new way to safely diagnose single-gene disorders in unborn babies using a simple blood test from the mother, starting as early as 9 weeks into the pregnancy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06147414

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.